Stephens Inc. AR Buys 877 Shares of Varonis Systems, Inc. $VRNS

Stephens Inc. AR lifted its stake in Varonis Systems, Inc. (NASDAQ:VRNS) by 10.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,934 shares of the technology company’s stock after buying an additional 877 shares during the period. Stephens Inc. AR’s holdings in Varonis Systems were worth $453,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in VRNS. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Varonis Systems by 43.7% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 6,681 shares of the technology company’s stock valued at $270,000 after buying an additional 2,031 shares during the period. Diversified Trust Co lifted its stake in shares of Varonis Systems by 62.7% in the first quarter. Diversified Trust Co now owns 24,595 shares of the technology company’s stock valued at $995,000 after buying an additional 9,482 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its stake in shares of Varonis Systems by 18.5% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,465 shares of the technology company’s stock valued at $352,000 after buying an additional 1,323 shares during the period. Peregrine Capital Management LLC lifted its stake in shares of Varonis Systems by 9.8% in the first quarter. Peregrine Capital Management LLC now owns 293,443 shares of the technology company’s stock valued at $11,870,000 after buying an additional 26,138 shares during the period. Finally, Teacher Retirement System of Texas lifted its stake in shares of Varonis Systems by 161.5% in the first quarter. Teacher Retirement System of Texas now owns 16,440 shares of the technology company’s stock valued at $665,000 after buying an additional 10,152 shares during the period. Institutional investors own 95.65% of the company’s stock.

Varonis Systems Stock Performance

NASDAQ:VRNS opened at $62.30 on Friday. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 1.32. The stock has a market capitalization of $6.98 billion, a P/E ratio of -67.72 and a beta of 0.64. The firm has a 50 day moving average of $58.97 and a 200-day moving average of $52.23. Varonis Systems, Inc. has a 1 year low of $36.53 and a 1 year high of $63.90.

Varonis Systems (NASDAQ:VRNS) last issued its quarterly earnings results on Tuesday, July 29th. The technology company reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.02. The business had revenue of $152.16 million during the quarter, compared to analyst estimates of $147.80 million. Varonis Systems had a negative net margin of 17.30% and a negative return on equity of 23.06%. Varonis Systems’s revenue for the quarter was up 16.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.05 earnings per share. Varonis Systems has set its FY 2025 guidance at 0.160-0.180 EPS. Q3 2025 guidance at 0.070-0.080 EPS. As a group, sell-side analysts anticipate that Varonis Systems, Inc. will post -0.83 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Den Bosch Fred Van sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $55.08, for a total value of $165,240.00. Following the completion of the sale, the director owned 128,666 shares of the company’s stock, valued at $7,086,923.28. This trade represents a 2.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Guy Melamed sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $59.59, for a total transaction of $89,385.00. Following the completion of the sale, the chief financial officer directly owned 412,105 shares of the company’s stock, valued at approximately $24,557,336.95. This represents a 0.36% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 113,386 shares of company stock valued at $6,429,405. 2.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. JPMorgan Chase & Co. increased their price target on shares of Varonis Systems from $61.00 to $70.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 24th. Jefferies Financial Group raised shares of Varonis Systems from a “hold” rating to a “buy” rating and increased their price target for the stock from $50.00 to $65.00 in a research report on Thursday, July 24th. Needham & Company LLC reissued a “buy” rating and issued a $70.00 price target on shares of Varonis Systems in a research report on Wednesday, September 3rd. B. Riley assumed coverage on shares of Varonis Systems in a research report on Tuesday, August 26th. They issued a “buy” rating and a $80.00 price target for the company. Finally, Morgan Stanley increased their price target on shares of Varonis Systems from $59.00 to $66.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 2nd. Fifteen analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $64.94.

About Varonis Systems

Varonis Systems, Inc provides software products and services that allow enterprises to manage, analyze, alert, and secure enterprise data in North America, Europe, the Middle East, Africa, and internationally. Its software enables enterprises to protect data stored on premises and in the cloud, including sensitive files and emails; confidential personal data belonging to customers, and patients and employees' data; financial records; source code, strategic and product plans; and other intellectual property.